Newly Restructured Incyte Posts Flat Revenue, Widened Loss in Q4 | GenomeWeb

NEW YORK, Feb. 13 - Incyte Genomics on Wednesday reported widened loss over flat revenue in the fourth quarter as it gathers momentum to become a full-fledged drug developer.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."